(PharmaNewsWire.Com, April 29, 2017 ) Natural Killer Cells Therapies is increasingly being used for enhancing the immunity of the body and to increase the body capacity to kill cancer or foreign cells. The technology is driven by the effective role of the therapy in removing cancer cells, preventing reoccurrence, attacking cancer cells which T cells can’t attack. For a detailed analysis of the NK cells therapy and the future perspective in the market, Market Research Hub (MRH) has added a report titled as “Natural Killer Cells Therapies - Competitive Landscape, Technology and Pipeline Analysis, 2017” in the wide database. The report provides a complete SWOT analysis of the NK cells therapy which covers various drivers and constraints.
Natural killer cells therapy is done by activating the NK cells to the maximum extent. The method is different than the conventional one. In NK cell therapy, lymphocytes are collected from patients’ blood and among these lymphocytes, natural killer cells are cultured and grown in large amounts, their ability to kill cancer is enhanced or activated. Then, NK cells are returned back to the patients’ body in order to further strengthen their immunity.
At first, the report starts with the introduction, scope and executive summary of the natural killer cells therapy which includes NK cell therapies and NK cell augmenting therapies. Further, leading companies with next generation technology is listed followed by market drivers, barriers and SWOT analysis. Moving further, the report describes the NK based therapy in detail and its target. The key players’ collaboration with deal year and the deal value is provided. Licensing agreement for future development and institute involved are also listed in brief. Moving further, the under development NK cells therapeutics is detailed under various phases, including Mid Stage Products (Phase II), Early Stage Products (Phase I and IND) and Pre-Clinical Products. The report has provided the therapeutic assessment of natural killer cell therapies, segmented as:
Assessment by Monotherapy Products Assessment by Combination Products Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type Assessment by Domain Assessment by Stage and Domain
Similarly, the NK cells augmenters (Enhancers and Activators) are analyzed with companies and therapeutic phases. The report also provides in-depth analysis of the Natural Killer Cell-based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, technologies and targeted antigens.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of therapeutic area market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : press@marketresearchhub.com Website : http://www.marketresearchhub.com/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
